Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback